ORGANOVO HOLDINGS, INC. Contracts & Agreements

Organovo Holdings, Inc. – Amended and Restated 2022 Equity Incentive Plan (Filed With SEC on November 22, 2024)

Description of Securities (Filed With SEC on May 31, 2024)

Form of Common Warrant (Filed With SEC on May 13, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 13, 2024)

Placement Agency Agreement, dated May 8, 2024, between the Company and JonesTrading Institutional Services LLC (Filed With SEC on May 13, 2024)

Form of Securities Purchase Agreement, dated May 8, 2024 (Filed With SEC on May 13, 2024)

Form of Placement Agency Agreement (Filed With SEC on April 30, 2024)

Form of Pre-Funded Warrant (Filed With SEC on April 30, 2024)

Form of Common Warrant (Filed With SEC on April 30, 2024)

Form of Securities Purchase Agreement (Filed With SEC on April 30, 2024)

Organovo Holdings, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on November 3, 2023)

Separation Agreement and General Release, effective as of September 27, 2023, between Organovo Holdings, Inc. and Jeffrey Miner (Filed With SEC on September 22, 2023)

Separation Agreement and General Release, effective as of September 15, 2023, between Organovo Holdings, Inc. and Tom Jurgensen (Filed With SEC on September 12, 2023)

Description of Securities (Filed With SEC on July 14, 2023)

Organovo Holdings, Inc. 2022 Equity Incentive Plan (Filed With SEC on October 14, 2022)

Description of Securities (Filed With SEC on June 10, 2022)

Settlement and Patent License Agreement, dated February 22, 2022, by and between Organovo Holdings Inc. and BICO Group AB (Filed With SEC on June 10, 2022)

Amended and Restated Lease Agreement dated November 23, 2020, between Organovo, Inc., as Tenant, and San Diego Inspire 2, LLC, as Landlord, as amended by First Amendment to... (Filed With SEC on November 19, 2021)

Organovo Holdings, Inc. Amended and Restated 2012 Equity Incentive Plan (As Amended & Restated on October 5, 2021) (Filed With SEC on October 6, 2021)

Amendment #5 dated October 4, 2021 to Consulting Agreement dated August 25, 2021 by and between Company and Danforth Advisors LLC (Filed With SEC on October 6, 2021)

Description of Securities (Filed With SEC on June 15, 2021)

Organovo Holdings, Inc. Amended and Restated 2012 Equity Incentive Plan (Filed With SEC on March 10, 2021)

Organovo Holdings, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on March 10, 2021)

Offer Letter, dated December 28, 2020, between the Company and Tom Jurgensen (Filed With SEC on February 8, 2021)

Intercompany Agreement, dated December 28, 2020, by and among Organovo Holdings, Inc., Organovo, Inc. and Viscient Biosciences, Inc (Filed With SEC on December 31, 2020)

Consulting Agreement, dated September 15, 2020, by and between Organovo and Multi Dimensional Bio Insight LLC (Filed With SEC on November 5, 2020)

Consulting Agreement, dated August 25, 2020, by and between Organovo and Danforth Advisors (Filed With SEC on November 5, 2020)

Offer Letter, dated September 15, 2020, between the Company and Jeffrey N. Miner (Filed With SEC on November 5, 2020)

Engagement Agreement, dated July 23, 2020, by and between Organovo and Optima Law Group of San Diego (Filed With SEC on November 5, 2020)

Cooperation Agreement, dated July 14, 2020, between the Company and Keith Murphy (Filed With SEC on July 15, 2020)

Form of Release Agreement by Keith Murphy in favor of the Companys directors and officers (Filed With SEC on July 15, 2020)

Form of Separation and Mutual Release Agreement with the Companys directors (Filed With SEC on July 15, 2020)

Form of Separation Agreement and Release with the Companys officers (Filed With SEC on July 15, 2020)

Description of Securities (Filed With SEC on May 28, 2020)

Amendment to Organovo Holdings, Inc. Severance and Change in Control Plan, dated May 19, 2020 (Filed With SEC on May 20, 2020)

First Amendment to Merger Agreement, dated January 26, 2020, by and among Organovo, Merger Sub and Tarveda (Filed With SEC on January 29, 2020)

Fifth Amended and Restated Investor Rights Agreement, dated December 12, 2019, by and between Tarveda Therapeutics, Inc. and the stockholders party thereto (Filed With SEC on December 23, 2019)

License Agreement, dated September 14, 2016, by and between Tarveda Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc (Filed With SEC on December 23, 2019)

Loan and Security Agreement, dated March 29, 2019, among Oxford Finance LLC, the Lenders named therein, and Tarveda Therapeutics, Inc (Filed With SEC on December 23, 2019)

Warrant to Purchase Stock issued by Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) to Comerica Bank, dated February 8, 2012 (Filed With SEC on December 23, 2019)

Warrant to Purchase Stock issued by Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) to Comerica Bank, dated November 19, 2013 (Filed With SEC on December 23, 2019)

First Amendment to Lease, dated February 23, 2012, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) (Filed With SEC on December 23, 2019)

Second Amendment to Lease, dated January 8, 2013, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) (Filed With SEC on December 23, 2019)

Third Amendment to Lease, dated April 19, 2016, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc (Filed With SEC on December 23, 2019)

Fourth Amendment to Lease, dated May 31, 2019, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc (Filed With SEC on December 23, 2019)

Tarveda Therapeutics, Inc. (formerly Blend Biosciences, Inc.) 2011 Stock Incentive Plan (Filed With SEC on December 23, 2019)

Employment Agreement, dated March 2, 2015, by and between Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) and Andrew J. Fromkin (Filed With SEC on December 23, 2019)

First Amendment to Employment Agreement, dated April 6, 2016, by and between Tarveda Therapeutics, Inc. and Andrew J. Fromkin (Filed With SEC on December 23, 2019)

Employment Agreement, dated December 19, 2017, by and between Tarveda Therapeutics, Inc. and Brian Roberts (Filed With SEC on December 23, 2019)

Employment Agreement, dated July 27, 2018, by and between Tarveda Therapeutics, Inc. and Jeffrey Bloss (Filed With SEC on December 23, 2019)

Form of Tarveda Therapeutics, Inc. Nondisclosure, Noncompetition and Assignment of Intellectual Property Agreement (Filed With SEC on December 23, 2019)

Lease, dated December 12, 2011, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) (Filed With SEC on December 23, 2019)

Form of Support Agreement, by and between Organovo, Tarveda and certain directors, officers and stockholders of Tarveda (Filed With SEC on December 16, 2019)

Form of Support Agreement, by and between Tarveda, Organovo and certain directors and officers of Organovo (Filed With SEC on December 16, 2019)

Form of Lock-Up Agreement, by and among Tarveda, Organovo and certain directors and officers of Tarveda and Organovo (Filed With SEC on December 16, 2019)

Agreement and Plan of Merger and Reorganization, dated as of December 13, 2019, by and among Organovo, Merger Sub and Tarveda (Filed With SEC on December 16, 2019)

Amended and Restated 2012 Equity Incentive Plan (Filed With SEC on July 27, 2018)

Sales Agreement, dated March 16, 2018, by and among the Company, H.C. Wainwright & Co., LLC and JonesTrading Institutional Services LLC (Filed With SEC on March 16, 2018)

ORGANOVO HOLDINGS, INC. CONTINUED SERVICE, CONSULTING AND SEPARATION AGREEMENT (Filed With SEC on April 11, 2017)

9,000,000 Shares Organovo Holdings, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 25, 2016)

ORGANOVO HOLDINGS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 18, 2016)

ORGANOVO HOLDINGS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Retention Form) (Filed With SEC on August 4, 2016)

ORGANOVO HOLDINGS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Executive Form) (Filed With SEC on August 4, 2016)

ORGANOVO HOLDINGS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Employee Form) (Filed With SEC on August 4, 2016)

ORGANOVO HOLDINGS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Non-Employee Director Form) (Filed With SEC on August 4, 2016)

CONSULTING, SEPARATION AGREEMENT AND RELEASE (Filed With SEC on April 5, 2016)

ORGANOVO HOLDINGS, INC. CONSULTING AGREEMENT (Filed With SEC on April 5, 2016)

oRGANOVO HOLDINGS, INC. severance AND CHANGE IN CONTROL plan (Effective as of November 4, 2015) (Filed With SEC on November 9, 2015)

ORGANOVO HOLDINGS, inc. SEVERANCE AND CHANGE IN CONTROL PLAN PARTICIPATION AGREEMENT (Filed With SEC on November 9, 2015)

ORGANOVO HOLDINGS, INC. AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN (Filed With SEC on August 24, 2015)

9,425,000 Shares Organovo Holdings, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 18, 2015)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN STOCK OPTION AWARD AGREEMENT (dIRECTORS) (Filed With SEC on June 9, 2015)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN STOCK OPTION AWARD AGREEMENT (EXECUTIVE) (Filed With SEC on June 9, 2015)

RESEARCH COLLABORATION AGREEMENT between ORGANOVO, INC. and LOREAL USA PRODUCTS, INC. Dated as of March 31, 2015 TABLE OF CONTENTS (Filed With SEC on June 9, 2015)

ORGANOVO HOLDINGS, INC. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on December 30, 2014)

FIRST AMENDMENT TO LEASE (Filed With SEC on February 6, 2014)

AMENDMENT NO. 2 TO THE 2012 EQUITY INCENTIVE PLAN (Filed With SEC on February 6, 2014)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN STOCK OPTION AWARD AGREEMENT (EXECUTIVE) (Filed With SEC on February 6, 2014)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (EXECUTIVE) (Filed With SEC on February 6, 2014)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (PERFORMANCE BASED) (Filed With SEC on February 6, 2014)

Organovo Holdings, Inc. 4,000,000 Shares of Common Stock EQUITY DISTRIBUTION AGREEMENT Dated: November 27, 2013 TABLE OF CONTENTS (Filed With SEC on November 27, 2013)

ORGANOVO HOLDINGS, INC. AMENDMENT TO 2012 EQUITY INCENTIVE PLAN (Filed With SEC on August 23, 2013)

9,000,000 Shares of Common Stock par value $0.001 1,350,000 Over-Allotment Shares Organovo Holdings, Inc. UNDERWRITING AGREEMENT (Filed With SEC on August 2, 2013)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (EXECUTIVE) (Filed With SEC on August 9, 2012)

ORGANOVO HOLDINGS, INC. 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (PERFORMANCE BASED) (Filed With SEC on August 9, 2012)

ORGANOVO HOLDINGS, INC. EQUITY INCENTIVE AWARD AGREEMENT (Filed With SEC on August 9, 2012)

LICENSE AGREEMENT (Filed With SEC on May 11, 2012)

LICENSE AGREEMENT BETWEEN CLEMSON UNIVERSITY RESEARCH FOUNDATION AND Organovo, Inc. CURF #01-025 Patent# 7,051,654 Entitled Ink-Jet Printing of ViableCells CURF License Agreement # (Filed With SEC on May 11, 2012)

EXECUTIVE SUMMARY (Filed With SEC on March 30, 2012)

Effective Date: February __, 2012Void After: February __, 2017 ORGANOVO HOLDINGS, INC. PLACEMENT AGENT WARRANT (Filed With SEC on March 19, 2012)

Effective Date: [], 2011Void After: [], 2016 ORGANOVO, INC. SELLING AGENT WARRANT (Filed With SEC on March 19, 2012)

Effective Date: February __, 2012Void After: October 18, 2016 ORGANOVO HOLDINGS, INC. REPLACEMENT SELLING AGENT WARRANT (Filed With SEC on March 19, 2012)

SUBSCRIPTION AGREEMENT (Filed With SEC on March 19, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 19, 2012)

Organovo, Inc. 5871 Oberlin Drive, Suite 150 (Filed With SEC on March 19, 2012)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on March 19, 2012)

JOINDER AGREEMENT (Filed With SEC on March 19, 2012)

AGREED AND ACCEPTED TO:ORGANOVO, INC.ORGANOVO HOLDINGS, INC.By:/s/ Keith MurphyBy:/s/ Deborah LovigName: Keith MurphyName: Deborah LovigTitle:Chief Executive... (Filed With SEC on March 19, 2012)

ESCROW DEPOSIT AGREEMENT (Filed With SEC on March 19, 2012)

JOINDER AGREEMENT (Filed With SEC on March 19, 2012)

ESCROW DEPOSIT AGREEMENT (Filed With SEC on March 19, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 1, 2012)

Articles of Merger (PURSUANT TO NRS 92A.200)Page 1 USE BLACK INK ONLY - DO NOT HIGHLIGHTABOVE SPACE IS FOR OFFICE USE ONLY (Filed With SEC on February 3, 2012)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 3, 2012)

Delaware (Filed With SEC on February 3, 2012)

Articles of Merger (PURSUANT TO NRS 92A.200)Page 1 USE BLACK INK ONLY - DO NOT HIGHLIGHTABOVE SPACE IS FOR OFFICE USE ONLY (Filed With SEC on February 3, 2012)

Articles of Merger(PURSUANT TO NRS 92A.200)Page 1 (Filed With SEC on January 4, 2012)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on January 4, 2012)

Europa Capital Investments, LLC 100 Europa Drive Suite 455 Chapel Hill, NC 27517 (Filed With SEC on March 16, 2011)

PATENT LICENSE AGREEMENT (Filed With SEC on February 4, 2011)

Category

Industry

Companies

Contracts

ORGANOVO HOLDINGS, INC. Contracts & Agreements